Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort for Sleep Quality in Emphysema
NCT01602523Phase 3Unknown
- Sponsor
- Temple University
- Start
- Mar 2011
- Primary completion
- Apr 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of budesonide in emphysema (2 arms), sponsored by Temple University. Primary endpoint: Objective assessment of sleep quality at 28 days. Status: unknown.
02
Drugs
budesonide
03
Conditions
emphysema
Beyond the preview
Go deeper on NCT01602523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01602523.